DermBiont

DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.

Biotechnology Health Care Medical Therapeutics

$28M

Latest Funding

Series A2

Latest Funding Stage

2021-12-21

Funding Date

United States

Location

Boston, Massachusetts

City & State

Key Contacts
Unlock Contact Information

Upgrade to access founder details

Upgrade Now
Unlock Tech Stack Data

Upgrade to access technology insights

Upgrade Now

Similar Startups

Eikon Therapeutics
Eikon Therapeutics  Logo

Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.

Arsenale Bioyards
Arsenale Bioyards Logo

Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.

EvidenceHunt
EvidenceHunt Logo

EvidenceHunt is an AI-powered research assistant developed by medical professionals for healthcare research. Our focus is on delivering tools that streamline gathering and analyzing clinical evidence. With features like AI Chat for interactive queries and comprehensive Direct Search options, EvidenceHunt allows precise data retrieval andanalysis.

Avitia
Avitia Logo

Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms.